These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3135199)

  • 21. Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
    Achterrath-Tuckermann U; Weischer CH; Szelenyi I
    Pharmacology; 1988; 36(4):265-71. PubMed ID: 3380879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
    Detsouli A; Lefort J; Vargaftig BB
    Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
    Sánchez-Crespo M; Fernández-Gallardo S; Nieto ML; Baranès J; Braquet P
    Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological profile of 48740 R.P., a PAF-acether antagonist.
    Lefort J; Sedivy P; Desquand S; Randon J; Coëffier E; Maridonneau-Parini I; Floch A; Benveniste J; Vargaftig BB
    Eur J Pharmacol; 1988 Jun; 150(3):257-68. PubMed ID: 2843382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
    Altman R; Scazziota A; Rouvier J; Cacchione R
    Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of PAF-acether to induce in vivo neutrophil migration.
    Cunha FQ; Heluy-Neto NE; Klein A; Souza GE; Ferreira SH
    Agents Actions; 1988 Aug; 25(1-2):191-4. PubMed ID: 3055873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M; Lefort J; Malanchère E; Vargaftig BB
    Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAF-acether-induced synthesis of prostacyclin by human endothelial cells.
    D'Humières S; Russo-Marie F; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(1):13-9. PubMed ID: 3102256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.
    Lalau Keraly C; Delautier D; Delabassee D; Chignard M; Benveniste J
    Thromb Res; 1984 Jun; 34(6):463-71. PubMed ID: 6740569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres.
    Wichrowski B; Jouquey S; Broquet C; Heymans F; Godfroid JJ; Fichelle J; Worcel M
    J Med Chem; 1988 Feb; 31(2):410-5. PubMed ID: 3339611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets.
    Kloprogge E; de Haas GH; Gorter G; Akkerman JW
    Thromb Res; 1983 Mar; 29(6):595-608. PubMed ID: 6222507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
    Fouque F; Vargaftig BB
    Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil aggregating properties of PAF-acether and leukotriene B4.
    Ford-Hutchinson AW
    Int J Immunopharmacol; 1983; 5(1):17-21. PubMed ID: 6302012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of a role for PAF-acether in the pathophysiology of the shock state.
    Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
    Chignard M; Le Couedic JP; Coëffier E; Benveniste J
    Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
    Honey AC; Lad N; Tuffin DP
    Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.
    Bourgain RH; Maes L; Braquet P; Andries R; Touqui L; Braquet M
    Prostaglandins; 1985 Aug; 30(2):185-97. PubMed ID: 3931178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.